Cargando…
Identification and Validation of a Potent Dual Inhibitor of the P. falciparum M1 and M17 Aminopeptidases Using Virtual Screening
The Plasmodium falciparum PfA-M1 and PfA-M17 metalloaminopeptidases are validated drug targets for the discovery of antimalarial agents. In order to identify dual inhibitors of both proteins, we developed a hierarchical virtual screening approach, followed by in vitro evaluation of the highest scori...
Autores principales: | Ruggeri, Chiara, Drinkwater, Nyssa, Sivaraman, Komagal Kannan, Bamert, Rebecca S., McGowan, Sheena, Paiardini, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583420/ https://www.ncbi.nlm.nih.gov/pubmed/26406322 http://dx.doi.org/10.1371/journal.pone.0138957 |
Ejemplares similares
-
Screening the Medicines for Malaria Venture "Malaria Box" against the Plasmodium falciparum Aminopeptidases, M1, M17 and M18
por: Paiardini, Alessandro, et al.
Publicado: (2015) -
A metal ion–dependent conformational switch modulates activity of the Plasmodium M17 aminopeptidase
por: Webb, Chaille T., et al.
Publicado: (2022) -
Mapping the substrate specificity of the Plasmodium M1 and M17 aminopeptidases
por: Malcolm, Tess R., et al.
Publicado: (2021) -
Active site metals mediate an oligomeric equilibrium in Plasmodium M17 aminopeptidases
por: Malcolm, Tess R., et al.
Publicado: (2020) -
Sitagliptin does not inhibit the M1 alanyl aminopeptidase from Plasmodium falciparum
por: McGowan, Sheena
Publicado: (2013)